STOCK TITAN

VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale

(Positive)
Tags

VSee Health (NASDAQ:VSEE) outlined business performance after the May 31, 2026 strategic sale of VSee Lab and renewed focus on its iDoc telehealth platform and enterprise healthcare solutions.

Pro-forma results show 2025 revenue up 60% to $8 million and Q1 2026 revenue up 70% to $2.5 million, alongside an approximate $6 million annual reduction in operating expenses.

Several large multi-year IDN contracts signed in 2025 are ramping and expanding telehealth services. Management believes targeting $20 million revenue and profitability over the next 12 months is realistic, citing improved margins and lower operating costs.

Loading...
Loading translation...

Positive

  • Pro-forma 2025 revenue increased 60% to $8 million
  • Q1 2026 pro-forma revenue grew 70% to $2.5 million
  • Annual operating expenses reduced by approximately $6 million
  • Several large multi-year IDN contracts continue rolling out and adding revenue
  • Strategic sale of VSee Lab completed May 31, 2026 refocuses on core telehealth
  • Management targets $20 million revenue and profitability in the next 12 months

Negative

  • None.

News Market Reaction – VSEE

+4.41%
5 alerts
+4.41% Session close to close
+4.1% Peak in 1 hr 13 min
$6.19M Market Cap
0.2x Rel. Volume

In the Jun 22 session, VSEE gained 4.41%, reflecting a moderate positive market reaction. Argus tracked a peak move of +4.1% during that session. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement underscores sharp revenue growth, with pro-forma sales reaching $8M in 2025 and lo...
Analysis

This announcement underscores sharp revenue growth, with pro-forma sales reaching $8M in 2025 and lower expenses after the VSee Lab sale. History shows weak price follow-through; funding needs and resale activity remain key risks to monitor.

Key Figures

Revenue growth: 80% Revenue: $8 million Revenue growth: +60% +4 more
7 metrics
Revenue growth 80% 2025 telehealth and digital health revenue growth
Revenue $8 million Pro-forma 2025 revenue after focusing on iDoc and enterprise solutions
Revenue growth +60% Pro-forma 2025 revenue growth vs prior year
Q1 2026 revenue $2.5 million Pro-forma Q1 2026 revenue from iDoc and enterprise solutions
Revenue growth +70% Pro-forma Q1 2026 revenue growth vs prior-year quarter
Operating expense reduction $6.0 million Approximate annual reduction in operating expenses after VSee Lab sale
Revenue target $20 million Management 12‑month revenue objective mentioned by CEO

Historical Context

5 past events · Latest: Jun 11 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 11 business separation Positive -0.6% Completed sale of VSee Lab, retired shares, and consolidated CEO leadership.
Apr 01 earnings results Positive -5.9% Reported 2025 revenue growth and stronger balance sheet with lower expenses.
Mar 10 product launch Positive -6.1% Unveiled autonomous telehealth AI robot with scaled platform metrics.
Feb 05 strategic partnership Positive -0.7% Announced managed services partnership to expand digital health delivery.
Jan 29 webinar announcement Neutral +0.0% Promoted educational webinar on tele‑ICU and mobile ICU models.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Shares have often traded flat-to-lower following generally positive operational and financial updates.

Key Terms

idn
1 terms
idn medical
"Several large IDN (Integrated Health Network) multi-year contracts that were signed"
An IDN (Integrated Delivery Network) is a coordinated group of hospitals, clinics and other healthcare providers that operate together to deliver medical services and manage patient care across a region. For investors, IDNs matter because they often buy medical equipment, drugs and technology in large, consolidated contracts and their purchasing decisions, patient volumes and payment arrangements can significantly affect the revenues and growth prospects of healthcare suppliers—think of an IDN as a single large customer made up of many clinics and hospitals.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025

HOUSTON, TX / ACCESS Newswire / June 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026.

Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions:

  • +60% revenue growth to $8 million in 2025

  • +70% revenue growth to $2.5 million in Q1 2026

  • Approximate reduction of $6.0 million in annual operating expenses

Several large IDN (Integrated Health Network) multi-year contracts that were signed throughout 2025 are continuing to roll out, build revenue and add more telehealth services.

VSee Health Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented, "Nearly one month since our decision to separate out VSee Lab and we are already seeing improved operational and financial efficiencies. Our team is super driven to ramp and grow existing contracts and identify, prospect and close new contracts from our ever-expanding business pipeline. With our hospital network continuing to grow, margins continuing to improve and operating expenses continuing to be reduced, we believe can achieve $20 million revenue and profitability over the next 12 months is a realistic target."

About VSee Health, Inc.

VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.

Source: For more information, please visit our website: https://www.idocvms.com

Forward-Looking Statements

This press release contains certain statements that may be deemed to be forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of VSee Health, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about VSee Health and the risk factors that may affect the realization of forward-looking statements is set forth in the filings with the Securities and Exchange Commission ("SEC"), including the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at www.sec.gov.

All forward-looking statements speak only as of the date on which they are made. VSee Health undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement was made, except to the extent required by applicable securities laws.

Investors Contact:
Justin Smith
jsmith@idocvms.com

SOURCE: VSee Health



View the original press release on ACCESS Newswire

FAQ

What business update did VSee Health (NASDAQ:VSEE) announce on June 22, 2026?

VSee Health reported pro-forma revenue growth and cost reductions following the strategic sale of VSee Lab. According to VSee Health, 2025 revenue rose 60% to $8 million with significant operating expense cuts and expanding multi-year telehealth contracts.

How did VSee Health's revenue perform in 2025 after focusing on telehealth (VSEE)?

VSee Health reported 2025 pro-forma revenue of $8 million, a 60% increase year over year. According to VSee Health, this growth followed a focus on the iDoc telehealth platform and enterprise healthcare solutions, supported by several large multi-year IDN contracts.

What were VSee Health's Q1 2026 financial results for NASDAQ:VSEE?

VSee Health reported Q1 2026 pro-forma revenue of $2.5 million, up 70% year over year. According to VSee Health, this increase reflects momentum from its telehealth and digital health solutions and ongoing roll-out of large multi-year integrated health network contracts.

How much did VSee Health reduce annual operating expenses after the VSee Lab sale?

VSee Health estimates an approximate $6 million reduction in annual operating expenses. According to VSee Health, lower costs come alongside revenue growth from its iDoc telehealth platform, supporting improved financial efficiency and contributing to its goal of reaching profitability within 12 months.

What revenue and profitability targets did VSee Health (VSEE) set for the next 12 months?

VSee Health believes achieving $20 million in revenue and profitability over the next 12 months is realistic. According to VSee Health, this target is based on growing hospital networks, improving margins, reduced operating expenses, and a strong pipeline of telehealth and enterprise healthcare contracts.

How does the strategic sale of VSee Lab impact VSee Health's telehealth strategy?

The sale of VSee Lab allows VSee Health to refocus on its iDoc telehealth and enterprise solutions. According to VSee Health, this sharper focus has supported revenue growth, reduced annual operating expenses by about $6 million, and improved operational and financial efficiencies.